Union Health Ministry convenes national consultation and experience-sharing workshop to advance nursing education and ecosystem
Union Ministry of Health and Family Welfare, in collaboration with the World Health Organization (WHO) and Jhpiego, convened a three-day National Consultation and Experience Sharing Workshop, starting today, on Nursing Policy Priorities and Best Practices in India to strengthen policy dialogue and advance reforms in the nursing and midwifery sector. The workshop brought together key […]
QCI and BHEL jointly organize Inter PSU Gunvatta Manthan to promote quality and operational excellence in PSUs
The Quality Council of India (QCI), in association with Bharat Heavy Electricals Limited (BHEL), organized the Inter PSU Gunvatta Manthan at its headquarters in New Delhi. Discussions during the event underlined QCI’s role in advancing the national quality movement through structured frameworks and excellence models. Participating PSUs shared their experiences and initiatives in areas such […]
TB incidence in India drops by 21% from 237 per lakh population in 2015 to 187 per lakh population in 2024 – almost double the rate of decline observed globally
India’s TB incidence (new cases emerging each year) reduced by 21% – from 237 per lakh population in 2015 to 187 per lakh population in 2024 – over almost double the pace of the decline observed globally at 12 %, as per the World Health Organization’s Global TB Report 2025. This is one of the […]
Healthcare affordability a key priority for the Government; duty cuts and GST reductions benefitting citizens: Union Minister of Commerce & Industry Shri Piyush Goyal
Union Minister of Commerce & Industry, Shri Piyush Goyal, while addressing the 22nd CII Annual Health Summit in New Delhi today, pointed out that India’s healthcare sector has benefitted from the Government’s continued focus on affordability—such as reducing GST on health and life insurance from 18 per cent to 0 per cent, and lowering duties […]
The Union Minister of Commerce and Industry, Shri Piyush Goyal Reaffirms Government’s Commitment to Promoting Quality Manufacturing and Implementation of QCOs at Udyog Samagam 2025
The Union Minister of Commerce and Industry, Shri Piyush Goyal, emphasized the Central Government’s commitment to supporting States and Union Territories in ensuring that high-quality products reach consumers across the country while addressing the second edition of Udyog Samagam 2025, organised by the Department for Promotion of Industry and Internal Trade (DPIIT). The Minister stated […]
India Joins Global #MedSafetyWeek Campaign to Promote Safe Use of Medicines
The National Coordination Centre – Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission (IPC), participated in the tenth edition of the global #MedSafetyWeek campaign, held from 3-9 November 2025, along with 130 partner organisations worldwide. Speaking at the occasion, Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, stated that, the research indicates that only 5–10% of all […]
NHA renews MoU with DHR and ICMR to strengthen evidence-based healthcare decision-making
The National Health Authority (NHA), the implementing agency of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and the Ayushman Bharat Digital Mission (ABDM), has renewed its Memorandum of Understanding (MoU) with the Department of Health Research (DHR) and the Indian Council of Medical Research (ICMR). The renewed collaboration aims to further strengthen technical cooperation […]
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis
Basel, 10 November 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the first Phase III (FENhance 2) of two pivotal, similarly-designed Phase III studies (FENhance 1 and 2) in patients with relapsing multiple sclerosis (RMS) met its primary endpoint. Fenebrutinib, an investigational Bruton’s tyrosine kinase (BTK) inhibitor, significantly reduced the annualised relapse […]
Simplification in Corneal Transplantation Rules to Boost Cornea Donation and Transplantation Services
The Ministry of Health and Family Welfare in alignment with the Government’s vision to promote equitable access to organ and tissue transplantation services has notified the Transplantation of Human Organs and Tissues (Amendment) Rules, 2025 under the Transplantation of Human Organs and Tissues Act, 1994 on 6th November, 2025. This amendment which further strengthens the National Organ Transplant Programme (NOTP), aims to […]
Positive phase III data for Roche’s Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus
Basel, 3 November 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today statistically significant and clinically meaningful results from the phase III ALLEGORY study of Gazyva®/Gazyvaro® (obinutuzumab) in adults with systemic lupus erythematosus (SLE) on standard therapy. The study met its primary endpoint showing a higher percentage of people achieved a minimum four-point improvement […]
